DNA/RNA Extraction Kit Market Size
The DNA/RNA extraction kit market reached US$3.40 billion in 2025, increased to US$3.70 billion in 2026, and is expected to reach US$ 7.66 billion by 2035, growing at a CAGR of 9.0% during the forecast period 2026 to 2035.
DNA and RNA extraction is a combination of chemical and physical processes involved in isolating DNA or RNA. Extraction by chemical method involves utilizing extraction kits to detect and extract DNA/RNA from the sample. Extraction kits simplify extraction by eliminating the need for mechanical disruption and decreasing hands-on time. Moreover, enhanced protocols for specific samples deliver reproducible purification of high-quality DNA/RNA.
DNA/RNA Extraction Kit Market Key Takeaways
- The market is forecast to expand from US$ 3.40 billion in 2025 to US$ 7.66 billion by 2035, reflecting sustained demand for molecular biology workflows.
- Automation-friendly extraction technologies are becoming the preferred choice for clinical laboratories, research institutions, and biopharmaceutical companies seeking faster and reproducible sample preparation.
- North America remains the largest regional market due to strong genomic research infrastructure, clinical laboratory adoption, and the presence of major manufacturers.
- Asia-Pacific is expected to record the fastest growth, supported by increasing biotechnology investments and expanding molecular diagnostic capabilities.
- Cell-free DNA (cfDNA) extraction continues to represent the leading product category owing to its expanding role in oncology diagnostics and liquid biopsy applications.
- Technology providers are investing heavily in automated magnetic bead-based extraction systems and improved purification chemistries to improve workflow efficiency.
DNA/RNA Extraction Kit Market Scope
| Metrics | Details |
| Market Size (2025) | US$ 3.40 Billion |
| Market Size (2035) | US$ 7.66 Billion |
| CAGR (2026-2035) | 9.00% |
| Historic Years | 2023-2024 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Segments Covered | Type, End User, Region |
| Largest Regional Market | North America |
| Fastest Growing Region | Asia-Pacific |
For know more Insights - Download Sample
DNA/RNA Extraction Kit Market Dynamics
The DNA/RNA extraction kit market growth is driven by the growing funding for R&D of extraction kits, advancement in technology, and increased automation in DNA/RNA extraction technology majorly drive the market. In addition, an increase in demand for user-friendly products boosts the growth of this market.
Growing advancement in technology is expected to drive the growth in the forecast period
Advancement in automation technologies, resulting in more accurate and effective analysis. Global key players have developed many new and broad range of DNA/RNA extraction kits that are fast, accurate and easy to use to analyze microorganisms, animal, food and environmental samples. DNA/RNA extraction kits have been optimized with PCR and electrophoresis equipment for rapid identification and quantification of DNA/RNA samples. The isolated DNA/RNA can be used directly in PCR assays using tailor-made kits that efficiently work with all types of sample matrices. DNA/RNA extraction techniques are performed in hospital laboratories, diagnostic laboratories, academic & research laboratories, biopharmaceutical companies, forensic laboratories and contract research organizations.
Lack of new product awareness coupled with the high cost of nucleic acids extraction kits is expected to hinder the growth in the forecast period
Lack of awareness of products for the scientists and laboratories which is used to complete complicated pathogen and disease screening procedure with a streamlined process, quality results, and leveraged lab efficiency and high cost of kits $5500 is the major factors hampering the market growth.
DNA/RNA Extraction Kit Market Segment Analysis
The cell-free DNA (cfDNA) segment is expected to hold the largest share in this market segment
Cell-free DNA (or cfDNA) refers to all non-encapsulated DNA in the bloodstream. A portion of that cell-free DNA originates from a tumor clone and is called circulating tumor DNA (or ctDNA). cfDNA is nucleic acid fragments that enter the bloodstream during apoptosis or necrosis. These kits tout a simple and automation-friendly protocol that allows users to quickly extract from a range of sample volumes, high-quality downstream ready cfDNA.
The laboratory segment is expected to hold largest share in this market segment
Most labs use commercial DNA extraction kits, which employ spin columns, for the isolation of DNA and RNA. The spin columns contain a silica resin that selectively binds DNA and RNA, depending on the salt conditions and other factors influenced by the extraction method. These account for the largest share of the segment.
DNA/RNA Extraction Kit Market Geographical Share
North America region holds the largest market share of the global DNA/RNA extraction kit market
North America is anticipated to be the leading regional market for DNA/RNA extraction. Growing genomic and proteomic research along with research collaborations amongst research institutes and hospital laboratories for clinical DNA/RNA data analysis are some of the major developments that will fuel the growth of the DNA/RNA extraction market. The regional North American market for DNA/RNA extraction is also going to be driven by the presence of manufacturing hubs of key companies operating in the DNA/RNA extraction market.
Market Opportunities
The expanding application of precision medicine presents significant commercial opportunities for manufacturers of DNA/RNA extraction kits. Increasing adoption of liquid biopsy testing, companion diagnostics, and genomic sequencing requires standardized extraction workflows capable of producing high-quality nucleic acids from diverse sample types.
Biotechnology companies can benefit from growing pharmaceutical research activities, while automation solution providers have opportunities to develop integrated extraction systems supporting high-throughput laboratory operations. Regional manufacturers in Asia-Pacific may also gain competitive advantages by offering cost-effective extraction kits tailored to local clinical laboratory requirements.
DNA/RNA Extraction Kit Companies
The global DNA/RNA extraction kit market is moderately competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include Thermo Fisher Scientific Inc, Primerdesign, QIAGEN N.V., RevoluGen, Bioneer corp, BioFire Defense, General Biosystems, Akonni Biosystems, Promega Corporation, Bio-Rad Laboratories, and many more. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.
Bio-Rad Laboratories
Overview: Bio-Rad, founded in 1952, is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With employees, more than 7,800, headquarters Hercules, California, USA. Bio-Rad is among the top five life science companies globally, providing instruments, software, consumables, reagents, and content for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. It is the world leader in clinical quality control products, services, and information systems, ensuring the accuracy and validity of clinical test results.
Product Portfolio: The Company’s portfolio comprised of include life science research and clinical diagnostics.
Recent Development-
- July 2025: Thermo Fisher Scientific expanded its KingFisher™ automated nucleic acid extraction portfolio, enhancing high-throughput DNA/RNA purification workflows with improved magnetic bead chemistry efficiency for clinical genomics and infectious disease testing applications.
- June 2025: QIAGEN expanded its global production capacity for RNA extraction kits and sample preparation technologies, focusing on scaling demand for infectious disease testing and precision medicine research applications across Europe and Asia-Pacific regions.
- May 2025: QIAGEN strengthened its QIAamp DNA/RNA extraction kit line with updated silica-membrane chemistry kits designed for improved viral RNA recovery in low viral-load samples, supporting next-generation molecular diagnostics workflows in the U.S. clinical laboratories.
- April 2025: Takara Bio enhanced its NucleoSpin and NucleoMag nucleic acid purification kits, introducing improved enzymatic lysis efficiency for difficult biological samples, strengthening its presence in academic and pharmaceutical research markets.
Why This Report Matters
This report supports strategic planning for:
- Molecular diagnostics manufacturers
- Biotechnology companies
- Pharmaceutical organizations
- Academic and research institutions
- Clinical laboratories
- Contract research organizations
- Healthcare investors
- Procurement teams
- Product development teams
- Strategic planning professionals
The report provides detailed market sizing, growth forecasts, competitive benchmarking, regional opportunity analysis, pricing trends, regulatory insights, supply chain assessment, and company strategies to support informed investment and commercialization decisions.
Conclusion
The DNA/RNA extraction kit market is positioned for sustained long-term expansion as molecular diagnostics, genomic sequencing, and precision medicine become increasingly integrated into healthcare and life science research. Continued investment in laboratory automation, improved purification technologies, and expanding applications across oncology, infectious diseases, and genetic testing will support market growth through 2035. Companies capable of delivering highly efficient, automation-compatible, and cost-effective extraction solutions while expanding manufacturing capacity and strengthening global distribution networks are expected to maintain a competitive advantage in this evolving molecular diagnostics market.
